CD274 and neoplasm: Overall, the expression of PD-L1 and tumor mutation burden level abundance have attracted great attention in immunotherapy.63,64,65,66 However, due to the deficiency of research data, we cannot perform a meta-regression analysis to factor in these potential biomarkers.